South Korean CRO MediCROstar Joins Medidata Solutions' Channel Partner Program
Medidata Solutions
announced that South Korean contract research organization (CRO)
MediCROstar
has joined Medidata’s channel partner program for CROs and other service providers. In addition to bringing the capabilities of the
Medidata Rave
electronic data capture (EDC) and clinical data management (CDM) solution, the partnership will enable MediCROstar to further expand its presence in the APAC region and continue to build its stake in the global clinical trials marketplace.
Founded in 2006, Seoul-based MediCROstar specializes in electronic case report format (eCRF) data management and protocol development for investigator-initiated trials. With experience managing clinical trials across South Korea and India, MediCROstar executives helped the Korea Food and Drug Administration (KFDA) write formal guidance on conducting EDC trials. As a result, the company has become a player in South Korea’s clinical development as the growth in clinical trials in the region has driven increasing need for technologies as well as outsourcing organizations to help efficiently manage the studies. MediCROstar looks to the Medidata partner program as a key driver of its global expansion and is developing new services around Medidata Rave to offer customers the efficient data management, local language capabilities and ease of use of the proven Rave platform.
“The adoption of EDC technology is a growing trend in South Korea, mirroring its use in the global pharmaceutical industry, and we have looked to Medidata’s partner program to help us field the increasing demand for innovative clinical technologies,” said Inyoung Choi, director, MediCROstar.
MediCROstar expects to leverage the Medidata Rave solution for a number of Phase III global multinational trials over the next year.
On September 10th, Medidata and MediCROstar will co-host a seminar titled “Safe Transfer – From Paper CRF to eCRF” at EL Tower, 24 Yangjae-dong, Seocho-gu, Seoul, South Korea. The seminar will outline the sponsor and CRO benefits of the Medidata Rave solution and introduce trends of data management in Korea. Presenters include Dong-Seok Yim, MediCROstar CEO, and Takeru Yamamoto, head of APAC at Medidata Solutions. For more information, please visit:
www.medicrostar.com
Medidata first announced its channel partner program in April 2005 to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, the program has grown to include over 25 partners. For more information, please visit:
www.mdsol.com/partnerships/cros.htm
.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
